Curis, Inc (CRIS) Covered Calls

Curis, Inc covered calls Curis, Inc. is a drug discovery and development company, which is engaged in developing medicines mainly in the field of cancer.

You can sell covered calls on Curis, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CRIS (prices last updated Thu 2:55 PM ET):

Curis, Inc (CRIS) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.79 +0.01 1.77 1.79 37K -1.2 0.1B
Covered Calls For Curis, Inc (CRIS)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
May 17 2.5 0.00 1.79 0.0% 0.0%
Jun 21 2.5 0.00 1.79 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Curis, Inc. is a biotechnology company, which is to develop and commercialize innovative drug candidates for the treatment of human cancers. Its pipeline includes two clinical stage drug candidates: CUDC-907, a dual HDAC and PI3K inhibitor, and CUDC-427, a small molecule IAP antagonist. The company conducts research programs both internally and through strategic collaborations. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.